Differential effects of endocannabinoids on [3H]-GABA uptake in the rat globus pallidus
Identifieur interne : 000901 ( PascalFrancis/Corpus ); précédent : 000900; suivant : 000902Differential effects of endocannabinoids on [3H]-GABA uptake in the rat globus pallidus
Auteurs : Katerina Venderov ; Timothy M. Brown ; Jonathan M. BrotchieSource :
- Experimental neurology : (Print) [ 0014-4886 ] ; 2005.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
In the globus pallidus, cannabinoid CB1 receptors are localized pre-synaptically on GABAergic neurons. We assessed the influence of the endocannabinoids, anandamide, 2-arachidonoyl-glycerol (2-AG) and noladin ether, on the uptake of [3H]-GABA in pallidal slices from rat. Both 2-AG and noladin ether increased [3H]-GABA uptake (by 40.8 ± 8.0% and 38.4 ± 12.5%). The effect of 2-AG was blocked by the cannabinoid CB1 receptor antagonist AM 251. In contrast, neither anandamide nor the agonist WIN 55,212-2 had an effect on [3H]-GABA uptake. Different roles might be played by different endocannabinoids, both physiologically and in basal ganglia disorders, such as Parkinson's disease.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 05-0317987 INIST |
---|---|
ET : | Differential effects of endocannabinoids on [3H]-GABA uptake in the rat globus pallidus |
AU : | VENDEROV (Katerina); BROWN (Timothy M.); BROTCHIE (Jonathan M.) |
AF : | Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419/Toronto, Ontario, M5T 258/Canada (1 aut., 3 aut.); School of Biological Sciences, University of Manchester/Manchester/Royaume-Uni (2 aut.) |
DT : | Publication en série; Courte communication, note brève; Niveau analytique |
SO : | Experimental neurology : (Print); ISSN 0014-4886; Coden EXNEAC; Etats-Unis; Da. 2005; Vol. 194; No. 1; Pp. 284-287; Bibl. 25 ref. |
LA : | Anglais |
EA : | In the globus pallidus, cannabinoid CB1 receptors are localized pre-synaptically on GABAergic neurons. We assessed the influence of the endocannabinoids, anandamide, 2-arachidonoyl-glycerol (2-AG) and noladin ether, on the uptake of [3H]-GABA in pallidal slices from rat. Both 2-AG and noladin ether increased [3H]-GABA uptake (by 40.8 ± 8.0% and 38.4 ± 12.5%). The effect of 2-AG was blocked by the cannabinoid CB1 receptor antagonist AM 251. In contrast, neither anandamide nor the agonist WIN 55,212-2 had an effect on [3H]-GABA uptake. Different roles might be played by different endocannabinoids, both physiologically and in basal ganglia disorders, such as Parkinson's disease. |
CC : | 002B16B; 002B17G |
FD : | Parkinson maladie; Cannabinoïde; GABA; Captation; Animal; Rat; Récepteur cannabinoïde CB1; Neurone gabaergique; Glycérol; Noyau gris central |
FG : | Rodentia; Mammalia; Vertebrata; Neurotransmetteur; Encéphale pathologie; Système nerveux central; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie; Système nerveux pathologie |
ED : | Parkinson disease; Cannabinoid; GABA; Uptake; Animal; Rat; CB1 cannabinoid receptor; Gabaergic neuron; Glycerol; Basal ganglion |
EG : | Rodentia; Mammalia; Vertebrata; Neurotransmitter; Cerebral disorder; Central nervous system; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Nervous system diseases |
SD : | Parkinson enfermedad; Canabinoide; GABA; Captación; Animal; Rata; Receptor canabinoide CB1; Neurona gabaminérgica; Glicerol; Núcleo basal |
LO : | INIST-9181.354000124651760240 |
ID : | 05-0317987 |
Links to Exploration step
Pascal:05-0317987Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Differential effects of endocannabinoids on [<sup>3</sup>
H]-GABA uptake in the rat globus pallidus</title>
<author><name sortKey="Venderov, Katerina" sort="Venderov, Katerina" uniqKey="Venderov K" first="Katerina" last="Venderov">Katerina Venderov</name>
<affiliation><inist:fA14 i1="01"><s1>Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419</s1>
<s2>Toronto, Ontario, M5T 258</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Brown, Timothy M" sort="Brown, Timothy M" uniqKey="Brown T" first="Timothy M." last="Brown">Timothy M. Brown</name>
<affiliation><inist:fA14 i1="02"><s1>School of Biological Sciences, University of Manchester</s1>
<s2>Manchester</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Brotchie, Jonathan M" sort="Brotchie, Jonathan M" uniqKey="Brotchie J" first="Jonathan M." last="Brotchie">Jonathan M. Brotchie</name>
<affiliation><inist:fA14 i1="01"><s1>Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419</s1>
<s2>Toronto, Ontario, M5T 258</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0317987</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0317987 INIST</idno>
<idno type="RBID">Pascal:05-0317987</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000901</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Differential effects of endocannabinoids on [<sup>3</sup>
H]-GABA uptake in the rat globus pallidus</title>
<author><name sortKey="Venderov, Katerina" sort="Venderov, Katerina" uniqKey="Venderov K" first="Katerina" last="Venderov">Katerina Venderov</name>
<affiliation><inist:fA14 i1="01"><s1>Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419</s1>
<s2>Toronto, Ontario, M5T 258</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Brown, Timothy M" sort="Brown, Timothy M" uniqKey="Brown T" first="Timothy M." last="Brown">Timothy M. Brown</name>
<affiliation><inist:fA14 i1="02"><s1>School of Biological Sciences, University of Manchester</s1>
<s2>Manchester</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Brotchie, Jonathan M" sort="Brotchie, Jonathan M" uniqKey="Brotchie J" first="Jonathan M." last="Brotchie">Jonathan M. Brotchie</name>
<affiliation><inist:fA14 i1="01"><s1>Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419</s1>
<s2>Toronto, Ontario, M5T 258</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Experimental neurology : (Print)</title>
<title level="j" type="abbreviated">Exp. neurol. : (Print)</title>
<idno type="ISSN">0014-4886</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Experimental neurology : (Print)</title>
<title level="j" type="abbreviated">Exp. neurol. : (Print)</title>
<idno type="ISSN">0014-4886</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal</term>
<term>Basal ganglion</term>
<term>CB1 cannabinoid receptor</term>
<term>Cannabinoid</term>
<term>GABA</term>
<term>Gabaergic neuron</term>
<term>Glycerol</term>
<term>Parkinson disease</term>
<term>Rat</term>
<term>Uptake</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Cannabinoïde</term>
<term>GABA</term>
<term>Captation</term>
<term>Animal</term>
<term>Rat</term>
<term>Récepteur cannabinoïde CB1</term>
<term>Neurone gabaergique</term>
<term>Glycérol</term>
<term>Noyau gris central</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In the globus pallidus, cannabinoid CB<sub>1</sub>
receptors are localized pre-synaptically on GABAergic neurons. We assessed the influence of the endocannabinoids, anandamide, 2-arachidonoyl-glycerol (2-AG) and noladin ether, on the uptake of [<sup>3</sup>
H]-GABA in pallidal slices from rat. Both 2-AG and noladin ether increased [<sup>3</sup>
H]-GABA uptake (by 40.8 ± 8.0% and 38.4 ± 12.5%). The effect of 2-AG was blocked by the cannabinoid CB<sub>1</sub>
receptor antagonist AM 251. In contrast, neither anandamide nor the agonist WIN 55,212-2 had an effect on [<sup>3</sup>
H]-GABA uptake. Different roles might be played by different endocannabinoids, both physiologically and in basal ganglia disorders, such as Parkinson's disease.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0014-4886</s0>
</fA01>
<fA02 i1="01"><s0>EXNEAC</s0>
</fA02>
<fA03 i2="1"><s0>Exp. neurol. : (Print)</s0>
</fA03>
<fA05><s2>194</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Differential effects of endocannabinoids on [<sup>3</sup>
H]-GABA uptake in the rat globus pallidus</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>VENDEROV (Katerina)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>BROWN (Timothy M.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BROTCHIE (Jonathan M.)</s1>
</fA11>
<fA14 i1="01"><s1>Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419</s1>
<s2>Toronto, Ontario, M5T 258</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>School of Biological Sciences, University of Manchester</s1>
<s2>Manchester</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA20><s1>284-287</s1>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>9181</s2>
<s5>354000124651760240</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>25 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>05-0317987</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Experimental neurology : (Print)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>In the globus pallidus, cannabinoid CB<sub>1</sub>
receptors are localized pre-synaptically on GABAergic neurons. We assessed the influence of the endocannabinoids, anandamide, 2-arachidonoyl-glycerol (2-AG) and noladin ether, on the uptake of [<sup>3</sup>
H]-GABA in pallidal slices from rat. Both 2-AG and noladin ether increased [<sup>3</sup>
H]-GABA uptake (by 40.8 ± 8.0% and 38.4 ± 12.5%). The effect of 2-AG was blocked by the cannabinoid CB<sub>1</sub>
receptor antagonist AM 251. In contrast, neither anandamide nor the agonist WIN 55,212-2 had an effect on [<sup>3</sup>
H]-GABA uptake. Different roles might be played by different endocannabinoids, both physiologically and in basal ganglia disorders, such as Parkinson's disease.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B16B</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Cannabinoïde</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Cannabinoid</s0>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Canabinoide</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>GABA</s0>
<s2>NK</s2>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>GABA</s0>
<s2>NK</s2>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>GABA</s0>
<s2>NK</s2>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Captation</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Uptake</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Captación</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Animal</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Animal</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Animal</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Rat</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Rat</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Rata</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Récepteur cannabinoïde CB1</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>CB1 cannabinoid receptor</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Receptor canabinoide CB1</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Neurone gabaergique</s0>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Gabaergic neuron</s0>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Neurona gabaminérgica</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Glycérol</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Glycerol</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Glicerol</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Noyau gris central</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Basal ganglion</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Núcleo basal</s0>
<s5>17</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Neurotransmetteur</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Neurotransmitter</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Neurotransmisor</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Système nerveux central</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Central nervous system</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervioso central</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>42</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>42</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>43</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>43</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>43</s5>
</fC07>
<fN21><s1>220</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 05-0317987 INIST</NO>
<ET>Differential effects of endocannabinoids on [<sup>3</sup>
H]-GABA uptake in the rat globus pallidus</ET>
<AU>VENDEROV (Katerina); BROWN (Timothy M.); BROTCHIE (Jonathan M.)</AU>
<AF>Toronto Western Research Institute, Toronto Western Hospital, 399 Bathurst Street, MC 11-419/Toronto, Ontario, M5T 258/Canada (1 aut., 3 aut.); School of Biological Sciences, University of Manchester/Manchester/Royaume-Uni (2 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Experimental neurology : (Print); ISSN 0014-4886; Coden EXNEAC; Etats-Unis; Da. 2005; Vol. 194; No. 1; Pp. 284-287; Bibl. 25 ref.</SO>
<LA>Anglais</LA>
<EA>In the globus pallidus, cannabinoid CB<sub>1</sub>
receptors are localized pre-synaptically on GABAergic neurons. We assessed the influence of the endocannabinoids, anandamide, 2-arachidonoyl-glycerol (2-AG) and noladin ether, on the uptake of [<sup>3</sup>
H]-GABA in pallidal slices from rat. Both 2-AG and noladin ether increased [<sup>3</sup>
H]-GABA uptake (by 40.8 ± 8.0% and 38.4 ± 12.5%). The effect of 2-AG was blocked by the cannabinoid CB<sub>1</sub>
receptor antagonist AM 251. In contrast, neither anandamide nor the agonist WIN 55,212-2 had an effect on [<sup>3</sup>
H]-GABA uptake. Different roles might be played by different endocannabinoids, both physiologically and in basal ganglia disorders, such as Parkinson's disease.</EA>
<CC>002B16B; 002B17G</CC>
<FD>Parkinson maladie; Cannabinoïde; GABA; Captation; Animal; Rat; Récepteur cannabinoïde CB1; Neurone gabaergique; Glycérol; Noyau gris central</FD>
<FG>Rodentia; Mammalia; Vertebrata; Neurotransmetteur; Encéphale pathologie; Système nerveux central; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie; Système nerveux pathologie</FG>
<ED>Parkinson disease; Cannabinoid; GABA; Uptake; Animal; Rat; CB1 cannabinoid receptor; Gabaergic neuron; Glycerol; Basal ganglion</ED>
<EG>Rodentia; Mammalia; Vertebrata; Neurotransmitter; Cerebral disorder; Central nervous system; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Nervous system diseases</EG>
<SD>Parkinson enfermedad; Canabinoide; GABA; Captación; Animal; Rata; Receptor canabinoide CB1; Neurona gabaminérgica; Glicerol; Núcleo basal</SD>
<LO>INIST-9181.354000124651760240</LO>
<ID>05-0317987</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000901 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000901 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:05-0317987 |texte= Differential effects of endocannabinoids on [3H]-GABA uptake in the rat globus pallidus }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |